AbbVie stock forecast and price prediction

ABBV stock price: $116.43 -0.15% At close on May 14th, 2021

Updated on:
May 17th, 2021


AbbVie forecast brief

  • AbbVie just moved a -0.15% after hitting all-time highs last Friday
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide.

AbbVie stock price forecast

Nobody can predict how much a stock will be priced in the future. Banks and financial organisations issue their analysis forecasting how a stock will performance in the future.

Along with buy or sell recommendations, brokerage institutions post their price target based on the stock price action and the company fundamental data. Most of these forecasts follow the publication of new fundamental information by the company, and many times. Again, these forecasts are not direct recommendations for individual investors and should not be followed blindly.

The average price target for AbbVie stock calculated from the table below is $127.50. That is a 9.51% than the current price ($116.43).

AbbVie stock price predictions
Brokerage firmPrice target
Apr 30th, 2021
Piper Sandler $120.00$124.00
May 3rd, 2021
BMO Capital Markets $127.00$129.00
Mizuho $126.00$128.00
May 10th, 2021
BMO Capital Markets $127.00$129.00

Analysts recommendations

In the last month, 4 ratings were published for AbbVie. General sentiment is bullish, with 4 out of 4 posting positive outlooks

AbbVie analysts' ratings - Last 30 days
Brokerage firmRating
Apr 30th, 2021
Piper Sandler Buy
May 3rd, 2021
BMO Capital Markets Buy
Mizuho Strong buy
May 10th, 2021
BMO Capital Markets Buy

Earnings and financials

In late April, AbbVie Inc. ($ABBV) reported EPS for that slightly enhanced Wall St. expectations. Quarterly EPS was $2.95 per share compared to the forecasted $2.83. This quarterly report represents an earnings surprise of 4.24%. On the contrary, reported sales were $13.0 billion, in line with analysts' forecasts.

Compared to the same quarter one year ago, EPS was $2.42, so posted EPS is a gain of 21.90%. Revenue exploded a 50.95% on an annualized basis in the , from $86.2B to $130.1B last quarter.

AbbVie ($ABBV) is hosting the Q2 earnings call next July. Market estimates of $3.08, compared to previous quarter that made $2.95.

AbbVie stock: buy or sell?

Is $ABBV stock a buy?

AbbVie received 4 ratings in the last 30 days: 4 bullish, 0 bearish and 0 neutral.

In the current situation of AbbVie there is not any eligible buy setup. This doesn't mean we expect a selloff for $ABBV in coming sessions, or that it may not climb higher. Simply, it doesn't match our recommended trading systems

Should I sell AbbVie?

In the current situation of AbbVie there is not any eligible sell setup, so AbbVie stock holders with operations in profit can keep their positions

AbbVie stock price action predictions

$ABBV at new Highs

Last Friday, AbbVie hit all-time highs (ATH) again at $117.59. It's the sixth time in the last 10 sessions, marking an important rally

SMAs overview

ABBV stock SMAs chart

Supports and resistances

Price is at all-time highs and there are not upper resistances.

The current supports are:

  • S1: $111.74 (-4.03% below)
  • S2: $109.75 (-5.74% below)
  • S3: $106.86 (-8.22% below)
  • Bollinger bands

    The price is moving near to the upper Bollinger band, signaling some level of overbought in recent sessions. This is not a sell signal, as price can trade in these levels for many days and weeks

    ABBV stock Bollinger Bands chart

    Relative strength index

    The RSI dropped below the overbought level of 70 last Tuesday after just crossing to the overbough zone for just one day (weak signal). The RSI reading last Friday was 68.33. Since RSI lost the overbought zone, AbbVie stock only moved a 0.18%

    ABBV stock RSI chart

    AbbVie stock price history

    AbbVie went public on Jan 2nd, 2013 at $24.66 per share1. Since then, ABBV stock surged by 372.14%, with an average of 46.52% per year. An investment of $1,000USD on the IPO would have a value of $4,721.41 nowadays.

    1: Adjusted price after possible price splits or reverse-splits

    ABBV stock price history chart

    The viewpoints contained in this article are personal and should not be followed as recommendations for you to buy or sell stocks. The author of this report does not know the individual positions of the reader, his or her finances or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Thoughts are posted for learning motives only

    AbbVie summary

    Friday, May 14th, 2021
    Day range$116.38 - $117.59
    Previous close$116.6
    Session gain-0.15%
    Average true range$2.26
    50d mov avg$108.36
    100d mov avg$106.69
    200d mov avg$98.75
    Earnings dateJuly 30th, 2021

    Frequently asked questions

    What is AbbVie stock symbol?

    AbbVie Inc. is a public company trading in the US stock market with the ABBV symbol

    Will ABBV go up?

    AbbVie had different price forecasts published by market analysts in the last 4 weeks forecasting the target price to $127.50. That is a 9.51% than the last price ($116.43).

    Latest AbbVie news